Florencio Mazzoldi

[GinkgoBits @GinkgoBits]

In our latest #GinkgoBits blog post, our Head of Software @BostonJamieCho explains what qPCR is, a term that you may have heard a lot during this #Covid_19 pandemic.

https://t.co/JtdT75NX1X

[GinkgoBits @GinkgoBits]

"So how much are we trying to accelerate COVID_19 vaccines?", you ask. https://t.co/rnVpvWYHUd

[Florencio Mazzoldi @fmazzoldi]

@GinkgoBits Carbon?

[Florencio Mazzoldi @fmazzoldi]

We’ve started to ship DNA to help #SARSCoV2 research this week. https://t.co/pfvh1FtUYt

[Florencio Mazzoldi @fmazzoldi]

I love this post about our pivot to #COVIDー19 work. @GinkgoBits @Ginkgo https://t.co/lGmJ0QL1Ws

[Keith Robison @OmicsOmicsBlog]

Just to beat the bushes again: We a @ginkgo are building a 10K/day SARS-CoV-2 sequencing operation to generate information for COVID-19 epidemiology. We're looking for RNA samples, both to validate our process and ultimately to feed the beast.

[GinkgoBits @GinkgoBits]

Hey tweetsters, take a look at https://t.co/OSxks8jPdo
where Birgitte, our Head of Sequencing, talks about how Ginkgo Bioworks (coolest company on the planet) is scaling out our already massive, highly-automated DNA/RNA sequencing capability to apply to #COVID19 research. Our

[Stephen Turner 🦋 @stephenturner.us @strnr]

Covid-19 papers from bioRxiv/medRxiv searchable and sortable https://t.co/9vwoLcIPJB

[Florencio Mazzoldi @fmazzoldi]

https://t.co/TIbfDKprqC

[Barney Pell @barneyp]

Breaking (potential breakthrough) early clinical trial results from France on HCQ, first well controlled study against COVID-19.

600 mg HCQ per day after 6 days, 90% of patients tested COVID-19 negative. 96% of control group tested positive after 6 days.

[Eric Topol @EricTopol]

What will go down as the biggest breakdown in the US response to #COVID19 is the lack of test kits. South Korea and the US had their 1st patients on Jan 20 and Jan 21, respectively. Look at the difference in daily testing. By March 4th, SK was ~18,000 per day.

[Ginkgo Bioworks @Ginkgo]

Thank you to everyone who's already responded! To clarify, this is open to teams worldwide, not just in the US https://t.co/Hxm0tGjN4b

[AWSonAir @AWSonAir]

Why cloud? Because of Moore’s Law with the engineering of organisms, says Florencio Mazzoldi, Head of Digital Technology at @ginkgo. “We engineer 3x more organisms every year. We were on-premises before, and we needed to scale.”

[Florencio Mazzoldi @fmazzoldi]

#BioIT18 this week. Let me know if you are here.

[Florencio Mazzoldi @fmazzoldi]

Protein engineers need help. https://t.co/Fz3TWSvSAl

[Florencio Mazzoldi @fmazzoldi]

It’s 2018, where are we with Machine Learning for Biology? @ATUM_bio @adskLifeScience https://t.co/DS4mh77Mes

[Molecule Viewer @moleculeviewer]

Our Molecule Viewer is published in this month's (December issue) Nature Methods! Check out the article (https://t.co/juFIoOdnyL) and experience it for yourself with this sample link: https://t.co/0o3RNYVmNv

[Florencio Mazzoldi @fmazzoldi]

Check out the Nature article on easy VR for molecular visualization with @adskLifeScience. https://t.co/fBeePR6mHC

[Florencio Mazzoldi @fmazzoldi]

Wow, all #iGEM2017 finalists were awesome.

[Florencio Mazzoldi @fmazzoldi]

Looking forward to #iGEM2017 this weekend.